School of Integrative Engineering, Chung-Ang University, Seoul 06974, Korea.
Department of Biomedical Engineering, Michigan State University, East Lansing, MI 48823, USA.
Biomolecules. 2020 Feb 15;10(2):308. doi: 10.3390/biom10020308.
Developing synthetic biological devices to allow the noninvasive control of cell fate and function, in vivo can potentially revolutionize the field of regenerative medicine. To address this unmet need, we designed an artificial biological "switch" that consists of two parts: (1) the electromagnetic perceptive gene (EPG) and (2) magnetic particles. Our group has recently cloned the EPG from the (glass catfish). The EPG gene encodes a putative membrane-associated protein that responds to electromagnetic fields (EMFs). This gene's primary mechanism of action is to raise the intracellular calcium levels or change in flux through EMF stimulation. Here, we developed a system for the remote regulation of [Ca] (i.e., intracellular calcium ion concentration) using streptavidin-coated ferromagnetic particles (FMPs) under a magnetic field. The results demonstrated that the EPG-FMPs can be used as a molecular calcium switch to express target proteins. This technology has the potential for controlled gene expression, drug delivery, and drug developments.
开发合成生物学装置以允许非侵入性地控制细胞命运和功能,这在体内有可能彻底改变再生医学领域。为了解决这一未满足的需求,我们设计了一种人工生物“开关”,它由两部分组成:(1)电磁感知基因(EPG)和(2)磁性颗粒。我们的团队最近从(玻璃猫鱼)中克隆了 EPG。EPG 基因编码一种假定的膜相关蛋白,对电磁场(EMF)作出反应。该基因的主要作用机制是通过 EMF 刺激提高细胞内钙离子水平或通量变化。在这里,我们开发了一种使用磁场下链霉亲和素包被的铁磁颗粒(FMP)远程调节[Ca](即细胞内钙离子浓度)的系统。结果表明,EPG-FMP 可用作分子钙开关来表达靶蛋白。这项技术具有控制基因表达、药物输送和药物开发的潜力。